Merck's PCV15 vaccine, Vaxneuvance, is now a competing vaccine with Pfizer's Prevnar 13 and Prevnar 20. Vaxneuvance was recently approved for Pediatric use. Please review our contract options moving forward:
Starting January 1st, 2023 PracticeWell Members have the choice to remain on the Pfizer contract for Prevnar 13 & Prevnar 20, or to remain on the Merck contract for all of the Merck manufactured vaccines. Pfizer and Merck have compliance commitments for each contract, so PracticeWell Members will no longer be able to participate on both contracts.
It is very important for us to know which contract you would like to use moving forward. As soon as possible, please contact us by phone or email to let us know if you would like to keep your PracticeWell PBG account linked to the Merck contract for all Merck products (do not order Prevnar and start using Merck's Vaxneuvance PCV15), or if you would like to keep your Pfizer account linked to Prevnar 13 and Prevnar 20. The choice is yours! We are available to answer any questions you may have.
Contact Joey Chebib, PracticeWell Membership Manager